Pharmacogenomics: a key component of personalized therapy

Por Schwab, Matthias, Schaeffeler, Elke
Publicado em 2012

Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer

Por Brauch, Hiltrud, Schwab, Matthias
Publicado em 2014

CYP2D6 genotyping and tamoxifen in the treatment of post-menopausal breast cancer – a reply

Por Brauch, Hiltrud, Schwab, Matthias
Publicado em 2014

Pediatric clinical pharmacology

Por Seyberth, Hannsjörg W., Rane, Anders, Schwab, Matthias
Publicado em 2011

Mechanisms and assessment of statin-related muscular adverse effects

Por Moßhammer, Dirk, Schaeffeler, Elke, Schwab, Matthias, Mörike, Klaus
Publicado no Br J Clin Pharmacol (2014)

Glucocorticoid exposure of sheep at 0.7 to 0.75 gestation augments late gestation fetal stress responses

Por Schwab, Matthias, Coksaygan, Turhan, Rakers, Florian, Nathanielsz, Peter W.
Publicado em 2011

Genetic Biomarkers in Epilepsy

Por Weber, Yvonne G., Nies, Anne T., Schwab, Matthias, Lerche, Holger
Publicado em 2014

Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy

Por Staiger, Harald, Schaeffeler, Elke, Schwab, Matthias, Häring, Hans-Ulrich
Publicado no Rev Diabet Stud (2015)

Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain

Por Antonow-Schlorke, Iwa, Schwab, Matthias, Li, Cun, Nathanielsz, Peter W
Publicado em 2003

Clinical Relevance of CYP2D6 Genetics for Tamoxifen Response in Breast Cancer

Por Brauch, Hiltrud, Schroth, Werner, Eichelbaum, Michel, Schwab, Matthias, Harbeck, Nadia
Publicado em 2008

Central Sleep Apnea Indicates Autonomic Dysfunction in Asymptomatic Carotid Stenosis: A Potential Marker of Cerebrovascular and Cardiovascular Risk

Por Rupprecht, Sven, Hoyer, Dirk, Hagemann, Georg, Witte, Otto W., Schwab, Matthias
Publicado em 2010

Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver

Por Klein, Kathrin, Winter, Stefan, Turpeinen, Miia, Schwab, Matthias, Zanger, Ulrich M.
Publicado em 2010

Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)

Por Nies, Anne T., Hofmann, Ute, Resch, Claudia, Schaeffeler, Elke, Rius, Maria, Schwab, Matthias
Publicado em 2011

Concomitant use of tamoxifen and endoxifen in postmenopausal early breast cancer: prediction of plasma levels by physiologically-based pharmacokinetic modeling

Por Dickschen, Kristin, Eissing, Thomas, Mürdter, Thomas, Schwab, Matthias, Willmann, Stefan, Hempel, Georg
Publicado em 2014

Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)

Por Niemi, Mikko, Kivistö, Kari T, Hofmann, Ute, Schwab, Matthias, Eichelbaum, Michel, Fromm, Martin F
Publicado em 2005

Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis

Por Riedmaier, Stephan, Klein, Kathrin, Winter, Stefan, Hofmann, Ute, Schwab, Matthias, Zanger, Ulrich M.
Publicado em 2011

Kinetics of Betamethasone and Fetal Cardiovascular Adverse Effects in Pregnant Sheep After Different Doses

Por Schwab, Matthias, Coksaygan, Turhan, Samtani, Mahesh N., Jusko, William J., Nathanielsz, Peter W.
Publicado em 2006

Genome Medicine: past, present and future

Por Auffray, Charles, Caulfield, Timothy, Khoury, Muin J, Lupski, James R, Schwab, Matthias, Veenstra, Timothy
Publicado em 2011

Looking back at genomic medicine in 2011

Por Auffray, Charles, Caulfield, Timothy, Khoury, Muin J, Lupski, James R, Schwab, Matthias, Veenstra, Timothy
Publicado em 2012

2012 highlights in translational 'omics

Por Auffray, Charles, Caulfield, Timothy, Khoury, Muin J, Lupski, James R, Schwab, Matthias, Veenstra, Timothy
Publicado em 2013